|
|
.
See Category: Injury, poisoning and certain other consequences of external causes
ICD-10 (CM) Code and Descriptor
|
T85.79XA |
Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts, initial encounter
|
T8579XA utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 58.04%
|
19.62%
|
7.95%
|
4.79%
|
2.55%
|
1.22%
|
0.61%
|
0.52%
|
0.55%
|
0.96%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for T85.79XA*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
1,025
|
1,057
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
766
|
787
|
|
J3010
|
FENTANYL CITRATE INJECTION |
750
|
1,366
|
|
87070
|
CULTURE OTHR SPECIMN AEROBIC |
686
|
787
|
|
J2405
|
ONDANSETRON HCL INJECTION |
684
|
3,021
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
678
|
692
|
|
87205
|
SMEAR GRAM STAIN |
656
|
771
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
624
|
16,817
|
|
80048
|
METABOLIC PANEL TOTAL CA |
623
|
628
|
|
80053
|
COMPREHEN METABOLIC PANEL |
619
|
619
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
560
|
2,508
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
522
|
523
|
|
87075
|
CULTR BACTERIA EXCEPT BLOOD |
521
|
624
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
507
|
1,788
|
|
J3370
|
VANCOMYCIN HCL INJECTION |
491
|
1,392
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
453
|
3,516
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
443
|
2,983
|
|
86140
|
C-REACTIVE PROTEIN |
435
|
436
|
|
87077
|
CULTURE AEROBIC IDENTIFY |
406
|
542
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
394
|
865
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
T85.79XA related to the following DRG Codes:
919-921
|
